<SEC-DOCUMENT>0001144204-15-054407.txt : 20150910
<SEC-HEADER>0001144204-15-054407.hdr.sgml : 20150910
<ACCEPTANCE-DATETIME>20150910160045
ACCESSION NUMBER:		0001144204-15-054407
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150910
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150910
DATE AS OF CHANGE:		20150910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		151101200

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v419946_8k.htm
<DESCRIPTION>8-K CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; border-bottom: Black 2pt double">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">FORM
8-K</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT PURSUANT TO SECTION 13
OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):
<B>September 10, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CHAMPIONS ONCOLOGY, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; text-align: justify; font-weight: bold">Delaware</TD>
    <TD STYLE="width: 37%; text-align: center; font-weight: bold">0-17263</TD>
    <TD STYLE="width: 33%; text-align: justify; font-weight: bold; padding-left: 0.75in">52-1401755</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: justify; padding-left: 0.75in"><FONT STYLE="font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-left: 0.75in"><FONT STYLE="font-size: 10pt">Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">1 University Plaza, Suite 307, Hackensack,
New Jersey 07601</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Registrant&rsquo;s telephone number, including
area code: <B>(410) 369-0365</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former Name or Former Address if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-bottom: Black 2pt double">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION TO BE INCLUDED IN THE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 10, 2015, Champion&rsquo;s
Oncology, Inc. (the &ldquo;Company&rdquo;) issued a press release regarding the Company&rsquo;s unaudited financial results for
its fiscal quarter ended July 31, 2015. A copy of the Company&rsquo;s press release is attached hereto as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information contained in this Current
Report shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibit filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exhibit No.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release dated September 10, 2015<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>CHAMPIONS ONCOLOGY, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 10pt">Date: September 10, 2015</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 34%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Joel Ackerman</FONT></TD>
    <TD STYLE="width: 14%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Joel Ackerman</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v419946_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 2.25pt solid; font-size: 10pt"><IMG SRC="tex99-1logo.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 2.25pt solid; padding-right: 0.5in; font-size: 10pt; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NEWS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #00000A">One University Plaza,
    Suite 307 Hackensack, NJ 07601 Tel: 201-808-8400</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>Champions Oncology Reports
Results for the First Quarter Ended July 31, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Hackensack, NJ &ndash;
September 10, 2015 &ndash; Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services
to personalize the development and use of oncology drugs, today announced its financial results for the first quarter ended July
31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">First Quarter and Recent
Business Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Completed
                                         uplisting to NASDAQ Capital Market</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Filed
                                         patent applications to develop humanized mice to be used in immune-oncology</TD></TR>                                                                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Announced additions to management team</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Joel Ackerman, Champions
Oncology CEO, stated, &ldquo;We continue to make progress in building the company. As the recognition of the value of patient
derived xenografts grows, we are being presented with many opportunities to expand our platform into new areas. We are pursuing
many of these opportunities in areas including immune oncology and clinical applications for our TOS customers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">For the first quarter
of 2015, revenue was $2.8 million, as compared to $1.9 million for the three months ended July 31, 2014, an increase of $892,000
or 47.6%. Total operating expenses for the first quarter 2015 were $5.7 million, as compared to $5.6 million for the three months
ended July 31, 2014, an increase of $78,000 or 1.4%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">For the first quarter
of 2015, Champions reported a loss from operations of $2.9 million as compared to a loss from operations of $3.7 million for the
three months ended July 31, 2014. Excluding stock-based compensation of $775,000 and $808,000 for the three months ended July
31, 2015 and 2014, Champions recognized a net loss of $2.1 million and $2.7 million respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>Operating Results </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>Personalized Oncology
Solutions (POS):</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A">POS revenue
was $485,000 and $341,000 for the three months ended July 31, 2015 and 2014, respectively, an increase of $144,000 or 42.2%. Core
revenue from its Champions TumorGraft&reg; technology platform decreased $16,000 or (4.9%). This decrease is due to a 21.6% decline
in implant revenue offset by a 6.3% increase in panel revenue. Non-core revenue increased $160,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">POS cost of sales was
$661,000 and $757,000 for the three months ended July 31, 2015 and 2014, respectively, a decrease of $96,000 or (12.7%). For the
three months ended July 31, 2015 and 2014, gross margins for POS were (36.3%) and (122%), respectively. The improvement in gross
margin is attributed to the increase in higher margin, non-core revenue and cost reductions in the core business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>Translational Oncology
Solutions (TOS): </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">TOS revenue was $2.3 million
and $1.6 million for the three months ended July 31, 2015 and 2014, respectively, an increase of $700,000, or 48.8%. The increase
is the result of increased bookings in prior quarters due to the expansion of the TOS sales team and the growth of the platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">TOS cost of sales was
$1.6 million and $965,000 for the three months ended July 31, 2015 and 2014, respectively, an increase of $647,000, or 67%. For
the three months ended July 31, 2015 and 2014, gross margin for TOS was 31% and 38.6%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; color: #00000A"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; color: #00000A">Research
and development expense was $1.1 million and $1.4 million for three months ended July 31, 2015 and 2014, respectively, a decrease
of $300,000, or (22.7%). </FONT><FONT STYLE="font-size: 10pt">The decrease is due to lower one-time expenses in genomic characterization
of our Champions TumorGraft Bank. <FONT STYLE="color: #00000A">Sales and marketing expense for both the three months ended July
31, 2015 and 2014 was $1 million. General and administrative expense for the three months July 31, 2015 and 2014 was $1.3 million
and $1.46 million, respectively a decrease of $145,000, or (9.9%). The decline is mainly due to a decrease in stock based compensation
expense of $105,000.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><FONT STYLE="color: #00000A"><B>&nbsp;</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>Conference Call Information
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">The Company will host
a conference call today at 4:00 p.m. EDT (1:00 p.m. PDT) to discuss its first quarter 2016 financial results. To access the conference
call, domestic participants should dial 800-875-3456, Canadian participants should dial 800-648-0973, and international participants
should dial 302-607-2001. The participant passcode is &ldquo;Champions Oncology.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A">Full details
of the Company&rsquo;s financial results will be available Friday, September 11, 2015 in the Company&rsquo;s Form 10-Q at</FONT>
<U>www.championsoncology.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>* Non-GAAP Financial
Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">See the attached Reconciliation
of GAAP net loss to non-GAAP net loss for an explanation of the amounts excluded to arrive at non-GAAP net loss and related non-GAAP
net loss per share amounts for the three months ended July 31, 2015 and 2014. Non-GAAP financial measures provide investors and
management with supplemental measures of operating performance and trends that facilitate comparisons between periods before and
after certain items that would not otherwise be apparent on a GAAP basis. Certain unusual or non-recurring items that management
does not believe affect the Company&rsquo;s basic operations do not meet the GAAP definition of unusual or non-recurring items.
Non-GAAP net loss and non-GAAP net loss per share are not, and should not be viewed as a substitute for similar GAAP items. Champions&rsquo;
defines non-GAAP dilutive loss per share amounts as non-GAAP net loss divided by the weighted average number of diluted shares
outstanding. Champions&rsquo; definition of non-GAAP net loss and non-GAAP diluted loss per share may differ from similarly named
measures used by others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Champions Oncology, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Champions Oncology, Inc. is engaged in
the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Champions
TumorGraft technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors
in immune deficient mice followed by propagation of the resulting engraftments, or Champions TumorGrafts, in a manner that preserves
the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The Company
uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions,
in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical
and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing
new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through
Champions&rsquo; Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release may contain &quot;forward-looking
statements&quot; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.
Champions Oncology generally uses words such as &quot;believe,&quot; &quot;may,&quot; &quot;could,&quot; &quot;will,&quot; &quot;intend,&quot;
&quot;expect,&quot; &quot;anticipate,&quot; &quot;plan,&quot; and similar expressions to identify forward-looking statements.
One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially
from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Oncology's Form 10-K for the
fiscal year ended April 30, 2015 for a discussion of such risks, uncertainties and other factors. Although the Company believes
the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which
the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet
these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release
to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>Champions Oncology,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><I>(Dollars in thousands
except per share amounts)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Reconciliation of
GAAP to Non-GAAP Net Loss (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months
    Ended<BR> July 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; color: black; text-align: left">Net loss - GAAP</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">(2,913</TD><TD STYLE="width: 1%; color: black; text-align: left">)</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">(3,548</TD><TD STYLE="width: 1%; color: black; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Less:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Stock-based compensation</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">775</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">808</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 2.5pt">Net (loss) income - non-GAAP</TD><TD STYLE="color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: right">(2,138</TD><TD STYLE="padding-bottom: 2.5pt; color: black; text-align: left">)</TD><TD STYLE="color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: right">(2,740</TD><TD STYLE="padding-bottom: 2.5pt; color: black; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Reconciliation of
GAAP EPS to Non-GAAP EPS (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months
    Ended<BR> July 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; color: black; text-align: left">Basic and diluted EPS &ndash; GAAP</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">(0.33</TD><TD STYLE="width: 1%; color: black; text-align: left">)</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">(0.64</TD><TD STYLE="width: 1%; color: black; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Less:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Effect of stock-based compensation on EPS</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">0.09</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">0.14</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 2.5pt">Basic and diluted EPS - non-GAAP</TD><TD STYLE="color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: right">(0.24</TD><TD STYLE="padding-bottom: 2.5pt; color: black; text-align: left">)</TD><TD STYLE="color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; text-align: right">(0.50</TD><TD STYLE="padding-bottom: 2.5pt; color: black; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Condensed Consolidated
Statements of Operations (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months
    Ended<BR> July 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; color: black; text-align: left">POS operating revenue</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">485</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">341</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">TOS operating revenue</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">2,337</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">1,571</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Total operating revenue</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right">2,822</TD><TD STYLE="padding-bottom: 1pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: right">1,912</TD><TD STYLE="padding-bottom: 1pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Cost of POS</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">661</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">757</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Cost of TOS</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,612</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">965</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Research and development</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,100</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,423</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Sales and marketing</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,029</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,034</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">1,317</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">1,462</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-left: 9pt">Loss from Operations</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="color: black; font-weight: bold; text-align: right">(2,897</TD><TD STYLE="color: black; font-weight: bold; text-align: left">)</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="color: black; font-weight: bold; text-align: right">(3,729</TD><TD STYLE="color: black; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Other (Expense) Income</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">(10</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">)</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">186</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-left: 9pt">Net Loss before income tax expense</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="color: black; font-weight: bold; text-align: right">(2,907</TD><TD STYLE="color: black; font-weight: bold; text-align: left">)</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="color: black; font-weight: bold; text-align: right">(3,543</TD><TD STYLE="color: black; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">6</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">5</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Net Loss</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">(2,913</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">)</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">(3,548</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Condensed Consolidated
Balance Sheets as of (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">July 31,</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">April 30,</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">2015</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">2015</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; color: black; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">6,760</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 10%; color: black; text-align: right">9,357</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Accounts receivable</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,458</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,060</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Other current assets</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">366</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">346</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-left: 9pt">Total current assets</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">8,584</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">10,763</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Restricted cash</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">150</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">163</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Property and equipment, net</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">445</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">452</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Goodwill</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">669</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">669</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total assets</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">9,848</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">12,047</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Accounts payable and accrued liabilities</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">$</TD><TD STYLE="color: black; text-align: right">1,852</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">$</TD><TD STYLE="color: black; text-align: right">1,787</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">1,907</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">2,009</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-left: 9pt">Total current liabilities</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">3,759</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">3,796</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Other Non-current liabilitiy</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">186</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">192</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Stockholders&rsquo; equity</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">5,903</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">8,059</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total liabilities
    and stockholders&rsquo; equity</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">9,848</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">12,047</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B><U>Condensed Consolidated
Statements of Cash Flows (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>July
                                         31,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(2,913</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(3,548</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net cash used in operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">775</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">808</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Depreciation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(155</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Changes in operating assets and liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(442</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">51</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(2,543</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(2,788</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Purchases of property and equipment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(33</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(29</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(33</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Payment of issuance costs related to 2015 Private Placement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Capital lease payments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(7</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in financing activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(25</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Exchange rate effect on cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase (decrease) in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,597</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,839</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash and cash equivalents, beginning of period</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,357</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,561</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,760</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,722</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tex99-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex99-1logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40#A P$1  (1 0,1 ?_$ +<   $#!0$!
M       ("0H! @4&!P0# 0 ! P4! 0              !@<( 0($!0D#"A
M  8! P($! 0% @,)     0(#! 4&!P 1""$2,1,4"4%1(A5AD3(6<8&AT2/P
M%['!0^'Q4H*2TC,8*!$  0($!0($ P0'!P('     0(# !$$!2$Q$@8'05%A
M(A,(<8$RD4)2%/"AL<%B(S/1X7*"0U,6) GQDK(T1!47_]H # ,!  (1 Q$
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M"%*P'[H]K)X]CG+>08N'#!^S6(NS?,G"S*0:+IB IKM';=1)RW4(8-P,0P"
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M,G&)LO!3A]%<-<+M,>M;%)6FPS3T;+=99=VY^SJV5V@FFY1K42JJ+>'AFQ2
M0H$(55R)?-6$3F^GE9RGO^LY*W0N]/--4]&E)2A"$@**0<-:I E1ZD_#*.ZO
M!'$3'#>RT6%+[U3<79*>*U$I2J6(0DF0 GTSA;(> ?P#3=IP2!*6&4/9%=5@
M@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@A O
MN0\AWG&_B=D2YP;T6-QL**% HZQ!_P B-@M?FL_N"  ('\R'C".711#])TBZ
M<SAO9HWMR+06NI -&@^H]V*425+YRE\XC][E>1%\;<37&YTZBBY5*C34Y$IA
M3B5 JSR2)D$8SE$')0QE#@<3*'6.<3*&.8RASF.83*',H81.<ZAQ$1$>HB.^
MNLS;+26&V$I#89\J G :.QC@RY4.U#JW*QQ2U+)45*Q)5W)_:<8ZQ@O"EYY
MY5I^(<>LR/;);Y$&Z:ZA%#,(B-1#SY>>E3D*!DHR&8E,LL;Q'8"%W,8H"G-[
M;KH=A[:=W-<E2;0DZ4B145$Z4X$CJ1UA8<>;$O?(^ZZ3:MC0?SM0\E))!_E)
MS4XJ0,@ "0>ID(FX\1^'^)N(V/6E.Q]$H.9]XT;'NE]?H(C9KA+%*!EG#MT
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MK3TQ'?H/C.*@H4>@;[].G3IO\1Z^&@&8GU[=1\8NG@%#Z29?IX1<8P%#<?F
M?G_'09] 3\(KX](^::I%0W+OMU\=OAMOX"/SU>I!09&+&W&W4ZV5!2.XR_7*
M*J*E2[>[?ZM]M@W\/GJT3)  )\>@^,7R4?I$_L_>1%P' ?#\/ETW\-^O31C^
MG7X128Q Q4,QU$6BJ4#=H[@/X[?WU1,U8@'3WBPNMI.E1DOM%OG$[NW8V_\
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M6V4L6"<\9(P;$SBB@/JE&@M+,FC1<YCJ1T;(LY>!DS1I .()HNCN03*(% 1
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M1,J03TG]V8&.':.D7M]]ZE/9[6QM'E(.%EH!#=8!,B1 2EP#ZA*?F,R !.)
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M1 0U!93 1Y5IDH8$$8CP([B.HS+U-4I"V]"@H S2=22#D0>H/>/>     ;[
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M:ZW)JQ7Y@U"W4T:BAEZ?T@R D>I&8.<::FNESIMN[AH&ZEQQBC)2R]/%()
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M-ICB"9<]+LRQ [@:KJB)F3HP&,R7,(["F<X:>GACEFNXWNYI;AZCFU'G 74
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MMZZK6HC_ .(M '^97E3/QA?.$?9?Y89)=LW62F]9PE63^6=TK8G[:>M)D#"
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?@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@C_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
